Cargando…

Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition

INTRODUCTION: Antihyperglycemic agents are significant contributors to adverse drug events, responsible for emergency department visits, hospitalizations, and death. Nationally, the rate of serious hypoglycemic events associated with these agents remains high despite widespread efforts to improve dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Munshi, Medha N., Sy, Sarah L., Florez, Hermes J., Huang, Elbert S., Lipska, Kasia J., Myrka, Anne, Marcos Valencia, Willy, Yu, Joyce, Triller, Darren M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934786/
https://www.ncbi.nlm.nih.gov/pubmed/35224691
http://dx.doi.org/10.1007/s13300-022-01216-0
_version_ 1784671916172247040
author Munshi, Medha N.
Sy, Sarah L.
Florez, Hermes J.
Huang, Elbert S.
Lipska, Kasia J.
Myrka, Anne
Marcos Valencia, Willy
Yu, Joyce
Triller, Darren M.
author_facet Munshi, Medha N.
Sy, Sarah L.
Florez, Hermes J.
Huang, Elbert S.
Lipska, Kasia J.
Myrka, Anne
Marcos Valencia, Willy
Yu, Joyce
Triller, Darren M.
author_sort Munshi, Medha N.
collection PubMed
description INTRODUCTION: Antihyperglycemic agents are significant contributors to adverse drug events, responsible for emergency department visits, hospitalizations, and death. Nationally, the rate of serious hypoglycemic events associated with these agents remains high despite widespread efforts to improve drug safety. Transitions of care between healthcare settings can lead to communication challenges between care professionals and increase the risk of adverse drug events. System-based improvements are needed to assure the safe transitions for patients with diabetes who are on antihyperglycemic agents. The objective of this study was to develop a consensus list of requisite elements that should be communicated between care settings during transitions of patients who are prescribed antihyperglycemic agents. METHODS: The Island Peer Review Organization (IPRO) Hypoglycemia Coalition identified suboptimal transitions of care as a barrier to improving patient safety and quality of diabetes care. The Coalition formed a multidisciplinary Task Force with experts in the field of diabetes care. The Task Force created a draft list of requisite communication elements through literature review and deliberation on monthly conference calls. A blinded iterative Delphi process was subsequently performed to generate a consensus list of requisite communication elements that participating experts agreed were necessary to safely and effectively assume the management of patients with diabetes upon care transitions. RESULTS: The Task Force completed a series of four iterative polls from September 2015 to August 2016, resulting in a final list of 22 requisite communication elements (the Diabetes Management Discharge Communication List), with the elements conceptually categorized into three domains: diagnosis and treatment, factors affecting glycemic control or patient risk, and patient self-management. CONCLUSIONS: The Diabetes Management Discharge Communication List provides an initial framework for the development of diabetes-specific resources to improve clinical communication between care settings.
format Online
Article
Text
id pubmed-8934786
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-89347862022-04-08 Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition Munshi, Medha N. Sy, Sarah L. Florez, Hermes J. Huang, Elbert S. Lipska, Kasia J. Myrka, Anne Marcos Valencia, Willy Yu, Joyce Triller, Darren M. Diabetes Ther Original Research INTRODUCTION: Antihyperglycemic agents are significant contributors to adverse drug events, responsible for emergency department visits, hospitalizations, and death. Nationally, the rate of serious hypoglycemic events associated with these agents remains high despite widespread efforts to improve drug safety. Transitions of care between healthcare settings can lead to communication challenges between care professionals and increase the risk of adverse drug events. System-based improvements are needed to assure the safe transitions for patients with diabetes who are on antihyperglycemic agents. The objective of this study was to develop a consensus list of requisite elements that should be communicated between care settings during transitions of patients who are prescribed antihyperglycemic agents. METHODS: The Island Peer Review Organization (IPRO) Hypoglycemia Coalition identified suboptimal transitions of care as a barrier to improving patient safety and quality of diabetes care. The Coalition formed a multidisciplinary Task Force with experts in the field of diabetes care. The Task Force created a draft list of requisite communication elements through literature review and deliberation on monthly conference calls. A blinded iterative Delphi process was subsequently performed to generate a consensus list of requisite communication elements that participating experts agreed were necessary to safely and effectively assume the management of patients with diabetes upon care transitions. RESULTS: The Task Force completed a series of four iterative polls from September 2015 to August 2016, resulting in a final list of 22 requisite communication elements (the Diabetes Management Discharge Communication List), with the elements conceptually categorized into three domains: diagnosis and treatment, factors affecting glycemic control or patient risk, and patient self-management. CONCLUSIONS: The Diabetes Management Discharge Communication List provides an initial framework for the development of diabetes-specific resources to improve clinical communication between care settings. Springer Healthcare 2022-02-28 2022-03 /pmc/articles/PMC8934786/ /pubmed/35224691 http://dx.doi.org/10.1007/s13300-022-01216-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Munshi, Medha N.
Sy, Sarah L.
Florez, Hermes J.
Huang, Elbert S.
Lipska, Kasia J.
Myrka, Anne
Marcos Valencia, Willy
Yu, Joyce
Triller, Darren M.
Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition
title Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition
title_full Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition
title_fullStr Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition
title_full_unstemmed Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition
title_short Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition
title_sort defining minimum necessary communication during care transitions for patients on antihyperglycemic medication: consensus of the care transitions task force of the ipro hypoglycemia coalition
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934786/
https://www.ncbi.nlm.nih.gov/pubmed/35224691
http://dx.doi.org/10.1007/s13300-022-01216-0
work_keys_str_mv AT munshimedhan definingminimumnecessarycommunicationduringcaretransitionsforpatientsonantihyperglycemicmedicationconsensusofthecaretransitionstaskforceoftheiprohypoglycemiacoalition
AT sysarahl definingminimumnecessarycommunicationduringcaretransitionsforpatientsonantihyperglycemicmedicationconsensusofthecaretransitionstaskforceoftheiprohypoglycemiacoalition
AT florezhermesj definingminimumnecessarycommunicationduringcaretransitionsforpatientsonantihyperglycemicmedicationconsensusofthecaretransitionstaskforceoftheiprohypoglycemiacoalition
AT huangelberts definingminimumnecessarycommunicationduringcaretransitionsforpatientsonantihyperglycemicmedicationconsensusofthecaretransitionstaskforceoftheiprohypoglycemiacoalition
AT lipskakasiaj definingminimumnecessarycommunicationduringcaretransitionsforpatientsonantihyperglycemicmedicationconsensusofthecaretransitionstaskforceoftheiprohypoglycemiacoalition
AT myrkaanne definingminimumnecessarycommunicationduringcaretransitionsforpatientsonantihyperglycemicmedicationconsensusofthecaretransitionstaskforceoftheiprohypoglycemiacoalition
AT marcosvalenciawilly definingminimumnecessarycommunicationduringcaretransitionsforpatientsonantihyperglycemicmedicationconsensusofthecaretransitionstaskforceoftheiprohypoglycemiacoalition
AT yujoyce definingminimumnecessarycommunicationduringcaretransitionsforpatientsonantihyperglycemicmedicationconsensusofthecaretransitionstaskforceoftheiprohypoglycemiacoalition
AT trillerdarrenm definingminimumnecessarycommunicationduringcaretransitionsforpatientsonantihyperglycemicmedicationconsensusofthecaretransitionstaskforceoftheiprohypoglycemiacoalition